BHYIX
Price
$7.19
Change
-$0.00 (-0.00%)
Updated
Nov 19 closing price
Net Assets
26.24B
JMADX
Price
$8.47
Change
-$0.00 (-0.00%)
Updated
Nov 19 closing price
Net Assets
165.99M
Interact to see
Advertisement

BHYIX vs JMADX

Header iconBHYIX vs JMADX Comparison
Open Charts BHYIX vs JMADXBanner chart's image
BlackRock High Yield Instl
Price$7.19
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets26.24B
JHancock Mgd Acct Shrs Non-IG CorpBdPort
Price$8.47
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets165.99M
BHYIX vs JMADX Comparison Chart in %
View a ticker or compare two or three
VS
BHYIX vs. JMADX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHYIX is a Hold and JMADX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BHYIX has more cash in the bank: 26.2B vs. JMADX (166M). JMADX pays higher dividends than BHYIX: JMADX (7.17) vs BHYIX (6.73). BHYIX was incepted earlier than JMADX: BHYIX (27 years) vs JMADX (6 years). JMADX (0.78) is less costly to investors than BHYIX (0.59). BHYIX is a more actively managed with annual turnover of: 74.00 vs. JMADX (43.00). JMADX has a lower initial minimum investment than BHYIX: JMADX (0) vs BHYIX (2000000). BHYIX annual gain was more profitable for investors over the last year : 7.39 vs. JMADX (6.62). BHYIX return over 5 years is better than : 27.97 vs. JMADX (21.04).
BHYIXJMADXBHYIX / JMADX
Total Expense Ratio0.580.00-
Annual Report Gross Expense Ratio0.590.7876%
Fund Existence27 years6 years-
Gain YTD7.1675.995120%
Front LoadN/AN/A-
Min. Initial Investment20000000-
Min. Initial Investment IRAN/AN/A-
Net Assets26.2B166M15,783%
Annual Yield % from dividends6.737.1794%
Returns for 1 year7.396.62112%
Returns for 3 years32.6429.51111%
Returns for 5 years27.9721.04133%
Returns for 10 years75.84N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUSEX40.700.16
+0.39%
MFS Blended Research Core Equity I
RLCAX9.24N/A
N/A
Columbia Disciplined Value A
DHTYX25.35N/A
N/A
Diamond Hill Select Y
SHPAX22.06N/A
N/A
Saratoga Health & Biotechnology A
DCCCX24.02N/A
N/A
Macquarie Small Cap Core C